Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Non-Hodgkin × Calcium Dobesilate × Clear all

Phase

Phase 2 8 Phase 1/2 3 Phase 1 3 Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Burkitt Lymphoma 7 Leukemia 6 Lymphoma 4 Recurrence 3 Prostatic Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms, Plasma Cell 2 Leukemia, Biphenotypic, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Hodgkin Disease 2 Breast Neoplasms 2 Vomiting 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Smoldering Multiple Myeloma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Nausea 1 Malignant Neoplasms of Male Genital Organs 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Inflammatory Breast Neoplasms 1 Hypersensitivity 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Down Syndrome 1

Interventions

Rituximab 53 Cyclophosphamide 32 Vincristine 24 Doxorubicin 22 Prednisone 20 Bendamustine Hydrochloride 16 Etoposide 13 Radiotherapy 11 Cytarabine 9 ibrutinib 6 fludarabine 6 VAP-cyclo protocol 6 Prednisolone 6 Peripheral Blood Stem Cell Transplantation 6 Granulocyte Colony-Stimulating Factor 6 Gemcitabine 6 Filgrastim 6 pirtobrutinib 5 ibritumomab tiuxetan 5 Methotrexate 5 Melphalan 5 Lenalidomide 5 pixantrone 4 Mitoxantrone 4 Epoetin Alfa 4 Cyclosporine 4 Carmustine 4 Bleomycin 4 venetoclax 3 tositumomab I-131 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06230224 2026-02-06

OLYMPIA-4

Regeneron Pharmaceuticals

Phase 3 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡